FERRLECIT

This brand name is authorized in Canada, Germany, Israel, United States

Active ingredients

The drug FERRLECIT contains one active pharmaceutical ingredient (API):

1 Sodium ferric gluconate complex in sucrose UNII CC9149U2QX - SODIUM FERRIC GLUCONATE COMPLEX

Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states. Read about Ferrous gluconate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FERRLECIT Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02243333
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02517463
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6979
Country: US	FDA, National Drug Code	Identifier(s): 0024-2792, 0024-2794